Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Jianzhou Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3721-6871; OpenAlex author ID A5079591368. Sources: OpenAlex.

Their work

Papers
15 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
32
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 3 papers · 2022: 1 paper · 2023: none · 2024: 5 papers · 2025: 4 papers

Papers 15

  1. NFE2-driven neutrophil polarization promotes pancreatic cancer liver metastasis progression. First author DOI 10.1016/j.celrep.2024.115226↗
  2. Co-assembly of natural small molecules into a carrier-free hydrogel with enhanced synergism for pancreatic cancer theranostic amplification. Co-author DOI 10.1016/j.mtbio.2025.101689↗
  3. Serum microRNA-24-based nomogram predicts prognosis for patients with resected pancreatic cancer. Co-author DOI 10.1038/s41598-024-82369-9↗
  4. NAMPT Modulates Gemcitabine Resistance in Pancreatic Cancer via the p53 Signaling Pathway. Co-author DOI 10.1097/mpa.0000000000002468↗
  5. Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic Cancer: A Multicenter Cohort Study. Co-author DOI 10.1007/s10620-024-08338-4↗
  6. Tumor microenvironment crosstalk between tumors and the nervous system in pancreatic cancer: Molecular mechanisms and clinical perspectives. First author DOI 10.1016/j.bbcan.2023.189032↗
  7. Targeted inhibition of CHKα and mTOR in models of pancreatic ductal adenocarcinoma: A novel regimen for metastasis. Co-author DOI 10.1016/j.canlet.2024.217280↗
  8. Obg-like ATPase 1 exacerbated gemcitabine drug resistance of pancreatic cancer. Co-author DOI 10.1016/j.isci.2024.110027↗
  9. MLH1 Inhibits Metastatic Potential of Pancreatic Ductal Adenocarcinoma via Downregulation of GPRC5C. Co-author DOI 10.1016/j.labinv.2024.102107↗
  10. Artificial intelligence in pancreatic cancer. Co-author DOI 10.7150/thno.77949↗
  11. MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal. Co-author DOI 10.1097/mpa.0000000000001920↗
  12. MicroRNAs in Pancreatic Cancer and Chemoresistance. Co-author DOI 10.1097/mpa.0000000000001934↗
  13. Aerial View of the Association Between m6A-Related LncRNAs and Clinicopathological Characteristics of Pancreatic Cancer. First author DOI 10.3389/fonc.2021.812785↗
  14. MicroRNA Detection with Turnover Amplification via Hybridization-Mediated Staudinger Reduction for Pancreatic Cancer Diagnosis. Co-author DOI 10.1021/jacs.9b11272↗
  15. Advance in microRNA as a potential biomarker for early detection of pancreatic cancer. First author DOI 10.1186/s40364-016-0074-3↗

Closest collaborators

The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gary Guishan Xiao · 9 shared papers, 2016–2025 · strength 1.62
  2. Junchao Guo · 8 shared papers, 2021–2025 · strength 1.62
  3. Wenchao Xu · 5 shared papers, 2024–2025 · strength 1.17
  4. Vay Liang W. Go · 5 shared papers, 2016–2025 · strength 0.78
  5. Li Zhou · 3 shared papers, 2021–2024 · strength 0.59
  6. Qiaofei Liu · 2 shared papers, 2024–2025 · strength 0.45
  7. Guoxu Ma · 2 shared papers, 2024–2025 · strength 0.43
  8. Jing Li Huang · 3 shared papers, 2016–2024 · strength 0.43
  9. Yongwei Sun · 2 shared papers, 2024–2025 · strength 0.39
  10. Minwei Yang · 2 shared papers, 2024–2025 · strength 0.39
  11. Jun Lü · 2 shared papers, 2021–2024 · strength 0.39
  12. Jing Huang · 2 shared papers, 2021–2025 · strength 0.38
  13. Junchao Guo · 2 shared papers, 2021–2025 · strength 0.35
  14. Ge Gao · 2 shared papers, 2021–2024 · strength 0.29
  15. Bowen Huang · 2 shared papers, 2021–2022 · strength 0.28
  16. Wen-Jing Liu · 1 shared paper, 2024 · strength 0.28
  17. Xufeng Tao · 2 shared papers, 2021 · strength 0.27
  18. Jiajia Xu · 1 shared paper, 2025 · strength 0.25
  19. Zhiyong Liang · 1 shared paper, 2025 · strength 0.25
  20. Qian Zhang · 1 shared paper, 2025 · strength 0.23
  21. Yong Jin Hou · 1 shared paper, 2025 · strength 0.23
  22. Bolun Jiang · 1 shared paper, 2024 · strength 0.20
  23. Dong Shang · 1 shared paper, 2024 · strength 0.20
  24. Zhigang Zhang · 1 shared paper, 2024 · strength 0.16
  25. Yefu Liu · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.